Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis

Mark M. Fuster, Lianchun Wang, Janice Castagnola, Lyudmila Sikora, Krisanavane Reddi, Phillip H.A. Lee, Katherine A. Radek, Manuela Schuksz, Joseph R. Bishop, Richard L. Gallo, P. Sriramarao, Jeffrey D. Esko

Research output: Contribution to journalArticlepeer-review

102 Scopus citations


To examine the role of endothelial heparan sulfate during angiogenesis, we generated mice bearing an endothelial-targeted deletion in the biosynthetic enzyme N-acetylglucosamine N-deacetylase/N-sulfotransferase 1 (Ndst1). Physiological angiogenesis during cutaneous wound repair was unaffected, as was growth and reproductive capacity of the mice. In contrast, pathological angiogenesis in experimental tumors was altered, resulting in smaller tumors and reduced microvascular density and branching. To simulate the angiogenic environment of the tumor, endothelial cells were isolated and propagated in vitro with proangiogenic growth factors. Binding of FGF-2 and VEGF164 to cells and to purified heparan sulfate was dramatically reduced. Mutant endothelial cells also exhibited altered sprouting responses to FGF-2 and VEGF164, reduced Erk phosphorylation, and an increase in apoptosis in branching assays. Corresponding changes in growth factor binding to tumor endothelium and apoptosis were also observed in vivo. These findings demonstrate a cell-autonomous effect of heparan sulfate on endothelial cell growth in the context of tumor angiogenesis.

Original languageEnglish (US)
Pages (from-to)539-549
Number of pages11
JournalJournal of Cell Biology
Issue number3
StatePublished - May 7 2007


Dive into the research topics of 'Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis'. Together they form a unique fingerprint.

Cite this